Skip to main content
Clinical Trials/CTRI/2024/01/061673
CTRI/2024/01/061673
Not yet recruiting
Phase 4

Comparative study on the therapeutic efficacy of topical bimatoprost (0.03%) ophthalmic solution and tacrolimus (0.1%) ointment in stable vitiligo. - NI

Eras Lucknow Medical College and Hospital0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: L80- Vitiligo
Sponsor
Eras Lucknow Medical College and Hospital
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Eras Lucknow Medical College and Hospital

Eligibility Criteria

Inclusion Criteria

  • Stable vitiligo patients involving less than 5 % of body surface area attending the dermatology OPD at Era Lucknow Medical College and Hospital

Exclusion Criteria

  • 1\. Vitiligo patients who took treatment in last 3 months
  • 2\. Patient having hypersensitivity to tacrolimus ointment and bimatoprost ophthalmic solution.
  • 3\. Pregnant and lactating women

Outcomes

Primary Outcomes

Not specified

Similar Trials